2012
DOI: 10.1259/bjr/27487871
|View full text |Cite
|
Sign up to set email alerts
|

MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity

Abstract: A simplified systematic imaging approach, in the order signal intensity, size and depth, would be a reference to distinguish between benign and malignant soft-tissue tumours for non-experts.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
56
2
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 73 publications
(64 citation statements)
references
References 16 publications
3
56
2
2
Order By: Relevance
“…Traditionally, a combination of patient demographic information, especially age, and imaging features are used to attempt to characterize lesions on the benign-malignant spectrum. Features such as large lesion size and greater depth, irregular margin, heterogeneity, and invasion of local structures, along with absence of deinitely benign features (eg, purely cystic), are regarded as concerning (1,5,6).…”
mentioning
confidence: 99%
“…Traditionally, a combination of patient demographic information, especially age, and imaging features are used to attempt to characterize lesions on the benign-malignant spectrum. Features such as large lesion size and greater depth, irregular margin, heterogeneity, and invasion of local structures, along with absence of deinitely benign features (eg, purely cystic), are regarded as concerning (1,5,6).…”
mentioning
confidence: 99%
“…In conventional proton MRI, T 2 is an important biomarker to discriminate tumor from healthy tissue, aiding in diagnosis and disease prognosis. However, MRI focuses on morphological changes whilst metabolic changes occur prior to any observable structural alterations, creating opportunities for MRSI . T 2 contrast in MRSI, however, is still not available in the clinic but may increase insight into diseases when used as a biomarker including relaxation information for each metabolite separately.…”
Section: Discussionmentioning
confidence: 91%
“…However, MRI focuses on morphological changes whilst metabolic changes occur prior to any observable structural alterations, creating opportunities for MRSI. 26,27 In our T 1 -weighted 31 P MRSI focusing on P i , we choose two T R and flip angle combinations, which remained close to and deviated from the optimal Ernst angle condition for cytosolic P i , allowing for T 1 weighting with the latter condition. Other metabolites are T 1 weighted in both situations; however, the weighting is amplified for PCr, PME and PDE, with T 1 relaxation rates of the order of several seconds (≥3.1 s), whereas the optimal Ernst angle condition is almost met for the βand γ-ATP resonances, with T 1 relaxation rates of around 1800 ms in the high flip angle experiment.…”
Section: Resultsmentioning
confidence: 99%
“…Unfortunately, most of the industry MRI recommendations are based on in vitro testing of homogenous tissue and phantom models. Homogenous models are commonly used for modeling malignant tumors, but do not accurately predict the SAR distribution within the heterogeneous distribution of tissues with varying electrical properties . Ullman and colleagues conducted a literature review of the DBS Brain Tissue Network for MRI‐related adverse events.…”
Section: Discussion Of Case Reportsmentioning
confidence: 99%